Cingulate Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cingulate Inc's ROI in the second quarter of 2026?
Cingulate Inc recorded a cumulative net loss of $-29 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -215.2%.

Within the Healthcare sector 713 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4190 to 4307.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	51.97 %	13.84 %	-18.57 %	145.19 %	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	24	20	5	5	7
Return On Investment (TTM)	-215.2 %	-308.26 %	-390.65 %	-313.87 %	-212.26 %
CING's Overall Ranking	# 4307	# 4190	# 3851	# 4105	# 3743
Seq. Investment Change TTM	48.79 %	57.83 %	-18.25 %	-20.84 %	11.46 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-29	-28	-22	-22	-19

CING Company Profile >> Back to CING Roi Comparisons >> See Annual CING Return On Investment

Return On Investment CING's Ranking
Within:	No.
Industry	# 336
Sector	# 714
Overall	# 4307

Return On Investment Statistics
High	Average	Low
-164.26 %	-331.69 %	-950.8 %
(Dec 31 2022)		(Jun 30 2023)

Financial Statements
Cingulate Inc's II. Quarter Investments	$ 24 Millions	CING's Balance sheet
Cingulate Inc's II. Quarter Income	$ -6 Millions	Quarterly CING's Income Statement
CING's Income by Division		See CING's Income by Division

CING Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	5	10	-7	4	21
Y / Y Investment Growth	-51.88 %	-	-	-81.38 %	-
Net Income in Millions	-22	-16	-24	-18	-21
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-471.57 %	-157.15 %	-	-455.34 %	-99.36 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CING's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CING's Competitors
Subscribers only: Roi for Cingulate Inc's Suppliers
Subscribers only: Return On Investment for CING's Customers

Other Ratios
CING's Roa	CING's Inventory Turnover Ratio	CING's Growth Rates	CING's Dividend Statistics
	CING's Profitability Ratios	CING's Asset Turnover Ratio	CING's Dividend Growth
CING's Roe	CING's Valuation Ratios	CING's Financial Strength Ratios	CING's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-08T17:05:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.